Skip to search formSkip to main contentSkip to account menu

taprostene

Known as: 2,3,4-trinor-1,5-inter-2-phenylene-6,9-epoxy-11,15-dihydroxy-15-dihydroxy-15-cyclohexyl-(16,17,18,19,20-pentanor)prosta-5,13-dienoate, Benzoic acid, 3-((4-(3-cyclohexyl-3-hydroxy-1-propenyl)hexahydro-5-hydroxy-2H-cyclopenta(b)furan-2-ylidene)methyl)-, monosodium salt, (3aR-(2Z,3aalpha,4alpha(1E,3S*),5beta,6aalpha))- 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

CG 4203

Broader (2)

Cardiovascular AgentsEpoprostenol
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Cochrane Database of Systematic Reviews Prostanoids for intermittent claudication (Review)
  • 2016
  • Corpus ID: 207854612
including different walking speeds and gradients. Such limitations in the data and the trial heterogeneity meant it was not… 
2009
2009
CellsExpression in Human Bronchial Epithelial Augments Glucocorticoid-Induced Gene Selective Prostacyclin Receptor Agonism
Prostacyclin receptor (IP-receptor) agonists display anti-inflammatory and antiviral activity in cell-based assays and in… 
1991
1991
Effects of prostacyclin and taprostene in splanchnic artery occlusion shock.
: Prostacyclin (PGI2) and taprostene (CG-4203) were studied in a highly lethal model of splanchnic artery occlusion (SAO) shock… 
1991
1991
Prostaglandins and -analogs in the treatment of platelet vessel wall interaction
Endogenous prostaglandins have been shown to beneficially affect the haemostatic balance. Experimental as well as clinical… 
1990
1990
A study of the effect of cotreatment with taprostene and saruplase on thrombolysis.